Imagine this: You're browsing through your social media feed, your fitness tracker buzzing on your wrist, reminding you to take a stroll. Now, imagine if that same wearable tech could do more than ...

DURHAM – Humacyte, a Durham-based regenerative medicine company, has begun a Phase 2 clinical trial of Humacyl, its bioengineered blood vessel, in patients with vascular trauma. The study will ...

Advent will establish a portfolio of vascular access solutions with the potential to address the key gaps in enabling haemodialysis to be delivered in alternative care environments Singapore-based ...

The deal comes less than a year after Vascular CEO Howard Root was acquitted on charges his business illegally promoted a line of medical devices. A Wayne-based medical device maker is spending $1 ...